Building on the momentum of last year’s Pharma & Life Sciences Spotlight, we’re launching the Global Pharma Summit – a new two-day experience embedded at the heart of HLTH.
Shaped by your feedback and the rapid growth of our pharma audience, this evolution brings senior leaders together on the showfloor while delivering the strategic depth the industry demands.
Join senior decision-makers to explore the forces defining the next decade. From scientific breakthroughs to regulatory change and market disruption and leave with sharper insight, stronger connections, and real opportunities.
We’re convening the key players of life sciences – C-suite leaders from pharma and biotech, top regulators, and senior innovators – for an exclusive, behind-closed-doors gathering.
C-suite and senior executives from global pharma and leading life sciences companies who steer portfolio strategy, investment decisions, and long-term enterprise direction.
Senior leaders responsible for shaping product strategy across the lifecycle, from generating evidence and engaging scientific communities to navigating pricing, access, and the commercial execution required for successful global launches.
Influential voices shaping the policy and regulatory frameworks that govern how innovation advances from early development to approval, access, and adoption.
Senior leaders and innovators from technology, AI, investment, who bring new approaches and partnership models that accelerate life sciences innovation.
sponsors backing the Summit
countries across every major European market
leading pharma organisations
senior attendees shaping global strategy
C-suite
Understand how shifts in science, policy, markets, and technology are shaping pharma’s next decade.
Explore collaborations with senior leaders across pharma, policy, technology, and investment in a focused, high-level environment.
See how new approaches in AI, evidence generation, and clinical development are influencing decisions from discovery to commercialisation.
Build meaningful connections with decision-makers who influence portfolio direction, policy, market access, and enterprise strategy.
Lu Zheng
VP, Head of Digital Health
Takeda Pharmaceuticals
